Skip to main content

Ibrahim Faruqi, MD, MPH

Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)

Photo of Ibrahim Faruqi
(352) 273-8740 MyUFHealth

Research at a glance

Top areas of exploration

  • Disease Progression , 2 publications
  • Pulmonary Embolism , 2 publications
  • Anti-Bacterial Agents , 2 publications
  • Respiratory Distress Syndrome , 2 publications

Research activity

12 publications

145 citations

Why is this important?

Focus

Biomarkers in Interstitial Lung Disease, Clinical Trials in Interstitial Lung Disease, Role of Th1 & Th2 pathways and biomarkers in Sarcoidosis

Active clinical trials

BLISSc-ILD

This study investigates the efficacy and safety of belimumab compared to placebo, in addition to standard therapy, for the treatment of participants with systemic sclerosis associated interstitial lung disease (SSc-ILD). The study will evaluate the…

Investigator
Ibrahim Faruqi
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
RIN-PF-302

Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis.

Investigator
Ibrahim Faruqi
Status
Accepting Candidates
Ages
40 Years - N/A
Sexes
All
TETON

Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.

Investigator
Ibrahim Faruqi
Status
Accepting Candidates
Ages
40 Years - N/A
Sexes
All

My publications

12 publications

2017

The Utility of the "Shred Sign" in the Diagnosis of Acute Respiratory Distress Syndrome Resulting from Multifocal Pneumonia.

American journal of respiratory and critical care medicine

PubMed • Publisher's site

2015

A 41-year-old woman with shortness of breath and history of rash and recurrent laryngeal edema.

Chest

PubMed • Publisher's site

2012

Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis.

The European respiratory journal

PubMed • Publisher's site

2010

Targeted delivery of amikacin into granuloma.

American journal of respiratory and critical care medicine

PubMed • Publisher's site